Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)
AST.WS
AST.WS was delisted on the 26th of September, 2017.
37 hedge funds and large institutions have $394K invested in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 10 reducing their positions, and 2 closing their positions.
445% more capital invested
Capital invested by funds: $72.2K → $394K (+$321K)
0% more funds holding
Funds holding: 37 → 37 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
90% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadwood Capital
New York
|
+$89.7K |
| 2 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$20.5K |
| 3 |
Goldman Sachs
New York
|
+$546 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TA
Teachers Advisors
New York
|
-$1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$290 |
| 3 |
Morgan Stanley
New York
|
-$61 |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$51 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$7 |
AST.WS Hedge Fund Activity: Q3 2016 in Review
37 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) for Q3 2016, worth a combined $394K — up 445% from $72.2K a quarter earlier.
Fund positioning in AST.WS was balanced in Q3 2016: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 10 trimmed.
The largest buyer was Broadwood Capital, opening a new position worth an estimated $89.7K. The largest seller was Teachers Advisors, exiting entirely with an estimated $1K sold.
- 37 institutional investors held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $394K of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) stock for Q3 2016, up 445% quarter-over-quarter.
- 2 funds opened new Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) positions in Q3 2016 and 2 closed out, a net change of 0 holders.
- The largest Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) buyer in Q3 2016 was Broadwood Capital, an estimated $89.7K added.
- The largest Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) seller in Q3 2016 was Teachers Advisors, an estimated $1K sold.
Based on aggregated 13F filings for Q3 2016.